Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EXAS

Exact Sciences Corp

Sep 15 • 03:52PM ET

53.35

-0.59 -1.10 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN GH NTRA TXG DGX FLGT BIO QDEL MYGN CSTM

| Held by: VTI VB ARKK VBK XBI VXF IWR FBT SCHM VHT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.42	Insider Own	1.37%	Shs Outstand	189.22M	Perf Week	-1.01%
Market Cap	10.10B	Forward P/E	100.69	EPS next Y	0.53	Insider Trans	-0.18%	Shs Float	186.73M	Perf Month	18.57%
Enterprise Value	11.78B	PEG	-	EPS next Q	-0.01	Inst Own	95.46%	Short Float	3.93%	Perf Quarter	-0.32%
Income	-1005.22M	P/S	3.44	EPS this Y	92.15%	Inst Trans	-2.52%	Short Ratio	2.33	Perf Half Y	18.55%
Sales	2.94B	P/B	4.09	EPS next Y	220.70%	ROA	-16.12%	Short Interest	7.34M	Perf YTD	-5.06%
Book/sh	13.05	P/C	11.77	EPS next 5Y	-	ROE	-35.51%	52W High	72.83 -26.75%	Perf Year	-16.80%
Cash/sh	4.53	P/FCF	59.54	EPS past 3/5Y	-17.13% -54.24%	ROIC	-20.23%	52W Low	38.81 37.45%	Perf 3Y	37.00%
Dividend Est.	-	EV/EBITDA	230.53	Sales past 3/5Y	16.01% 25.78%	Gross Margin	69.52%	Volatility	3.46% 3.27%	Perf 5Y	-28.54%
Dividend TTM	-	EV/Sales	4.01	EPS Y/Y TTM	-464.28%	Oper. Margin	-5.65%	ATR (14)	1.89	Perf 10Y	155.12%
Dividend Ex-Date	-	Quick Ratio	2.56	Sales Y/Y TTM	12.56%	Profit Margin	-34.19%	RSI (14)	61.11	Recom	1.46
Dividend Gr. 3/5Y	- -	Current Ratio	2.89	EPS Q/Q	92.66%	SMA20	7.27%	Beta	1.23	Target Price	64.27
Payout	-	Debt/Eq	1.03	Sales Q/Q	15.99%	SMA50	8.91%	Rel Volume	0.64	Prev Close	53.94
Employees	7000	LT Debt/Eq	1.01	Earnings	Aug 06 AMC	SMA200	3.60%	Avg Volume	3.15M	Price	53.35
IPO	Jan 31, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	92.08% 4.82%	Trades		Volume	1,979,340	Change	-1.10%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$60
Mar-13-25	Initiated	RBC Capital Mkts	Sector Perform	$52
Jan-23-25	Initiated	Barclays	Overweight	$70
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50

Show Previous Ratings

Today 09:45AM	Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term (Zacks)
Sep-12-25 11:30AM	Why Is Kodiak Sciences (KOD) Down 1.2% Since Last Earnings Report? (Zacks)
08:51AM	Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs (Zacks)
08:50AM	Exact Sciences price target raised to $85 from $65 at Craig-Hallum (TipRanks)
Sep-11-25 05:33PM	More Blood Tests for Cancer Hit the Market (Barrons.com)
10:04AM	Loading…
Sep-10-25 10:04AM	Should You Continue to Hold EXAS Stock in Your Portfolio? (Zacks)
06:30AM	Exact Sciences Launches Cancerguard, First-of-Its-Kind Multi-Cancer Early Detection Blood Test (Business Wire)
Sep-04-25 04:13PM	Why IBD 50's Guardant Health Just Tumbled, Breaking A 67% Monthlong Run (Investor's Business Daily)
02:36PM	Why Exact Sciences (EXAS) Stock Is Trading Up Today (StockStory)
12:30PM	What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? (Zacks)
Sep-03-25 12:36PM	Exact Sciences (EXAS) Stock Trades Up, Here Is Why (StockStory)
Aug-31-25 12:10AM	Jefferies Reiterates a Buy Rating on Exact Sciences Corporation (EXAS) (Insider Monkey)
Aug-29-25 12:40AM	3 of Wall Street's Favorite Stocks We're Skeptical Of (StockStory)
Aug-27-25 09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Aug-19-25 06:00AM	Exact Sciences to Participate in September Investor Conferences (Business Wire)
09:15AM	Loading…
Aug-15-25 09:15AM	TMO Receives FDA Approval for Oncomine Dx Target Test (Zacks)
12:02AM	2 Reasons to Sell EXAS and 1 Stock to Buy Instead (StockStory)
Aug-13-25 08:37AM	TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move? (Zacks) +7.59%
01:36AM	The Top 5 Analyst Questions From Exact Sciences's Q2 Earnings Call (StockStory)
Aug-12-25 10:30PM	[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:40PM	National Advertising Division Recommends Agendia Disclose Material Connection to Doctor Featured in Social Media Posts (GlobeNewswire)
08:27AM	EXAS Stock Dips Despite Q2 Earnings & Revenue Beat, '25 Sales View Up (Zacks)
03:06AM	EXAS Q2 Deep Dive: Portfolio Expansion and Productivity Drive Guidance Increase Amid Market Caution (StockStory)
Aug-11-25 11:07AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
09:45AM	Here's Why Exact Sciences (EXAS) is a Strong Growth Stock (Zacks)
09:06AM	Multi Cancer Early Detection Market Forecast Report 2025-2033: A $4.3 Billion Market by 2033, as Market Set to Quadruple from $1 Billion Valuation in 2024 (GlobeNewswire)
Aug-08-25 10:36AM	IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates (Zacks) -5.03%
10:26AM	PBYI's Q2 Earnings Beat Estimates, Nerlynx Sales Drive Revenues (Zacks)
Aug-07-25 04:19PM	Is Exact Sciences, Down 8%, 'Throwing Good Money At Bad' In Its New Licensing Deal? (Investor's Business Daily) -7.99%
02:56PM	Exact Sciences Dip A Chance To Buy As Freenome Deal Fortifies Future: Analyst (Benzinga)
01:35PM	Loading…
01:35PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
12:00PM	Exact Sciences (EXAS) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
11:20AM	MIRM Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
05:17AM	Exact Sciences to acquire US rights for Freenomes blood-based CRC test (Medical Device Network)
Aug-06-25 06:15PM	Exact Sciences (EXAS) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
05:27PM	Exact Sciences (NASDAQ:EXAS) Reports Strong Q2 But Stock Drops 15.2% (StockStory)
05:26PM	Exact Sciences Tumbles On Plans To License Blood-Based Colon Cancer Test (Investor's Business Daily)
05:09PM	Exact Sciences: Q2 Earnings Snapshot (Associated Press Finance)
04:12PM	How Exact Sciences Is Spending $775 Million To Dominate The Cancer-Screening Market (Investor's Business Daily)
04:06PM	Freenome Announces Exclusive License Agreement with Exact Sciences to Commercialize Freenome's Blood-Based Screening Test for Colorectal Cancer (PR Newswire)
04:05PM	Exact Sciences Announces Second Quarter 2025 Results (Business Wire)
04:05PM	Exact Sciences Announces Exclusive License with Freenome for Blood-Based Colorectal Cancer Screening Tests (Business Wire)
Aug-05-25 08:10AM	Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
08:00AM	Astrin Biosciences Expands Leadership Team with Chief Marketing Officer Jaime LaMontagne to Support Next Phase of Growth (PR Newswire)
Aug-04-25 11:18PM	Exact Sciences (EXAS) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
02:07PM	Viatris Poised to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
08:30AM	Zimmer Biomet to Report Q2 Earnings: Here's What to Expect (Zacks)
08:10AM	TG Therapeutics (TGTX) Misses Q2 Earnings Estimates (Zacks)
Aug-01-25 11:23AM	Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
08:50AM	Will Healthcare Growth Help STE Beat on Q1 Earnings? (Zacks)
06:45AM	Exact Sciences expands partnership with Humana to improve colorectal cancer screening (Medical Device Network)
Jul-31-25 08:54AM	Will Exact Sciences Corporation (EXAS) Continue to Penetrate the Market with Its Cologuard Test? (Insider Monkey)
07:00AM	Exact Sciences and Humana Expand Colorectal Cancer Screening Partnership with Cologuard Plus Test (Business Wire)
Jul-30-25 11:07AM	Perrigo to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
10:00AM	Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
08:20AM	Charles River Q2 Earnings Preview: What's in Store for the Stock? (Zacks)
Jul-29-25 01:43PM	Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report (PR Newswire)
09:14AM	Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards? (Zacks)
08:43AM	Tempus AI Taps Growing ICI Market With New xM Assay (Zacks)
08:26AM	Moderna to Report Q2 Earnings: Is a Beat in Store for the Stock? (Zacks)
08:07AM	Henry Schein to Report Q2 Earnings: What's in Store for the Stock? (Zacks)
Jul-28-25 11:40AM	KROS vs. EXAS: Which Stock Should Value Investors Buy Now? (Zacks)
10:36AM	CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards? (Zacks)
Jul-25-25 08:46AM	Altimmune Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
08:38AM	HOLX vs. EXAS: Which Cancer Diagnostics Stock Should You Retain Now? (Zacks)
12:03AM	3 Reasons EXAS is Risky and 1 Stock to Buy Instead (StockStory)
Jul-24-25 12:10PM	Amarin Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
11:42AM	Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards? (Zacks)
09:45AM	Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
08:40AM	SubjectWell Appoints Veteran Healthcare Finance Leader Karl Stubelis as Chief Financial Officer (PR Newswire)
Jul-21-25 09:38AM	Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect (Zacks)
Jul-18-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jul-16-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-15-25 09:55AM	Wall Street Analysts Think Exact Sciences (EXAS) Could Surge 26.24%: Read This Before Placing a Bet (Zacks)
09:20AM	Tempus AI Raises 2025 Financial Outlook: What's Backing It? (Zacks)
Jul-14-25 06:00AM	Exact Sciences Schedules Second Quarter 2025 Earnings Call (Business Wire)
12:36AM	1 Healthcare Stock for Long-Term Investors and 2 to Be Wary Of (StockStory)
Jul-10-25 11:40AM	QGEN or EXAS: Which Is the Better Value Stock Right Now? (Zacks)
Jul-09-25 06:00AM	Exact Sciences Announces Medicare Coverage for Oncodetect Molecular Residual Disease Test in Colorectal Cancer (Business Wire)
Jul-07-25 12:00PM	What Makes Exact Sciences (EXAS) a New Buy Stock (Zacks)
09:45AM	Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Jul-03-25 08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jul-02-25 08:11AM	What's Fueling Tempus AI's Explosive Sales Growth? (Zacks)
Jun-30-25 07:35AM	Concerns Rise Over Exact Sciences Corp. (EXAS) Salesforce Reorganization Affecting Growth (Insider Monkey)
Jun-27-25 04:25PM	Gilead, Exact Jump After The Supreme Court Upholds A 'Cornerstone' Of Health Care (Investor's Business Daily)
Jun-26-25 04:14AM	The 5 Most Interesting Analyst Questions From Exact Sciences's Q1 Earnings Call (StockStory)
Jun-24-25 11:40AM	QGEN vs. EXAS: Which Stock Is the Better Value Option? (Zacks)
Jun-23-25 01:37AM	Exact Sciences Expands Oncodetect Validation, Unveils MRD Innovation Roadmap. (Insider Monkey)
Jun-20-25 08:41AM	Tempus AI's 89% Genomics Surge: Will the Momentum Keep Building? (Zacks)
Jun-19-25 09:45AM	Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio (Zacks)
Jun-18-25 08:43PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
Jun-12-25 06:20AM	Should You Invest in the SPDR S&P Biotech ETF (XBI)? (Zacks)
Jun-11-25 11:36PM	A Look Back at Immuno-Oncology Stocks' Q1 Earnings: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Pack (StockStory)
Jun-09-25 08:42AM	Hologic Climbs 13% in a Month: How Should You Play the Stock? (Zacks)
Jun-05-25 11:30AM	CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue? (Zacks)
08:52AM	Should You Continue to Hold EXAS Sciences Stock in Your Portfolio? (Zacks)
Jun-04-25 05:31AM	Freenome posts pivotal liquid biopsy data as FDA filing nears completion (MedTech Dive)
May-28-25 06:05AM	Exact Sciences Announces Expanded Clinical Validation of the Oncodetect Test and Molecular Residual Disease Innovation Roadmap (Business Wire)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Doyle James Edward	Director	Aug 13 '25	Sale	42.02	1,485	62,400	59,962	Aug 14 04:30 PM
Doyle James Edward	Director	Aug 13 '25	Proposed Sale	42.02	1,485	62,400		Aug 13 10:09 AM
ORVILLE JACOB A	EVP, GM, Screening	Aug 05 '25	Option Exercise	0.00	5,350	0	30,752	Aug 07 05:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '25	Option Exercise	0.00	5,350	0	27,943	Aug 07 05:30 PM
Sebelius Kathleen	Former Director	Jul 16 '25	Proposed Sale	53.11	8,164	433,605		Jul 16 04:22 PM
Zanotti Katherine S	Director	Jun 13 '25	Sale	53.20	3,207	170,612	72,759	Jun 16 05:30 PM
Zanotti Katherine S	Director	Jun 13 '25	Proposed Sale	53.20	3,207	170,612		Jun 13 09:50 AM
Bloomer Aaron	EVP, Chief Financial Officer	Apr 15 '25	Option Exercise	0.00	24,460	0	19,340	Apr 17 04:30 PM
Conroy Kevin T	President and CEO	Mar 07 '25	Option Exercise	22.38	66,723	1,493,261	1,203,269	Mar 10 05:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 28 '25	Option Exercise	0.00	4,265	0	16,339	Mar 04 04:48 PM
Conroy Kevin T	President and CEO	Feb 28 '25	Option Exercise	0.00	40,310	0	1,146,965	Mar 04 04:47 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 28 '25	Option Exercise	0.00	9,673	0	25,106	Mar 04 04:44 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 28 '25	Option Exercise	0.00	9,673	0	27,728	Mar 04 04:40 PM
Condella Sarah	EVP, Human Resources	Feb 28 '25	Option Exercise	0.00	7,738	0	84,399	Mar 04 04:37 PM
Condella Sarah	EVP, Human Resources	Feb 25 '25	Option Exercise	0.00	3,954	0	80,297	Feb 26 08:00 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 25 '25	Option Exercise	0.00	3,954	0	19,841	Feb 26 08:00 PM
Herriott James	SVP, General Counsel & Sec	Feb 25 '25	Option Exercise	0.00	1,647	0	13,738	Feb 26 08:00 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 25 '25	Option Exercise	0.00	3,954	0	22,136	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 25 '25	Option Exercise	0.00	13,180	0	1,121,378	Feb 26 08:00 PM
Conroy Kevin T	President and CEO	Feb 19 '25	Option Exercise	0.00	10,374	0	1,084,565	Feb 21 04:30 PM
COWARD D SCOTT	Director	Feb 19 '25	Option Exercise	0.00	2,248	0	52,831	Feb 21 04:30 PM
ORVILLE JACOB A	EVP, GM, Screening	Feb 19 '25	Option Exercise	0.00	2,248	0	16,688	Feb 21 04:30 PM
Baranick Brian	EVP, GM, Precision Oncology	Feb 19 '25	Option Exercise	0.00	1,729	0	14,487	Feb 21 04:30 PM
Condella Sarah	EVP, Human Resources	Feb 19 '25	Option Exercise	0.00	2,248	0	74,859	Feb 21 04:30 PM
Herriott James	SVP, General Counsel & Sec	Feb 19 '25	Option Exercise	0.00	865	0	10,731	Feb 21 04:30 PM
Conroy Kevin T	President and CEO	Nov 13 '24	Buy	51.35	19,500	1,001,325	1,074,191	Nov 13 12:56 PM
Baranick Brian	EVP, GM, Precision Oncology	Oct 08 '24	Sale	70.00	929	65,030	12,758	Oct 09 05:00 PM
Baranick Brian	Officer	Oct 08 '24	Proposed Sale	70.00	929	65,030		Oct 08 01:27 PM
Baranick Brian	EVP, GM, Precision Oncology	Sep 18 '24	Sale	70.00	929	65,030	13,687	Sep 19 05:00 PM
Baranick Brian	Officer	Sep 18 '24	Proposed Sale	70.00	929	65,030		Sep 18 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp

Upgrade your FINVIZ experience